Ginkgo vs Saffron for mood: which has better evidence?
Saffron has the stronger evidence for mood (Ginkgo Grade C vs Saffron Grade B). For mood, Saffron has the stronger evidence grade.
Platform evidence comparison
These existing platform assessments are separate from the source-reported findings below. They do not represent a direct trial comparing these treatments.
| Ginkgo | Saffron | |
|---|---|---|
| Grade | grade C | grade B |
| Certainty | low | moderate |
| Effect | Systematic review and network meta-analysis of herbal anxiolytics: Ginkgo biloba showed a modest anxiety-reducing signal among the herbs assessed, but the evidence base is heterogeneous and of limited certainty. | multiple RCTs show benefit for mild-to-moderate depressive symptoms, comparable to low-dose SSRIs in small trials |
| Studied dose | not standardized | 30 mg/day |
| Population | adults with anxiety symptoms | adults with mild-moderate depression |
| Safety | 2 modeled interaction(s) | 0 modeled interaction(s) |
Grade C / low: hints of benefit in small trials; a well-run RCT could easily push this to B or to null.
Direct comparison evidence
There are no direct RCTs in our corpus comparing Ginkgo and Saffron head-to-head for mood. What we present above is an indirect comparison: each side's own trials, contrasted. This is standard practice for supplement comparisons — dose, population, and outcome-instrument differences between the two evidence bases add uncertainty on top of each side's own grade.
Can you take both?
No modeled interaction between Ginkgo and Saffron in our corpus. Absence of a recorded interaction is not proof of additive benefit — combined-effect trials are usually absent for supplement pairs, so treat "stack" claims skeptically.
Decision guidance
- If certainty matters most — choose whichever side carries the higher certainty rating at a similar grade.
- If you're on medications — check each side's interaction pages before deciding; safety differences dominate small evidence-grade gaps.
- If your population is under-studied — the smaller-effect side with better population evidence often wins over the higher-grade side studied in a different demographic.
- If cost matters — form and dose page differences (Ginkgo vs Saffron) can invert the practical winner.
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
Which has stronger evidence: Ginkgo or Saffron for mood?
Ginkgo carries Grade C at low certainty; Saffron carries Grade B at moderate. The stronger evidence points to Saffron, subject to the caveat that direct head-to-head trials are usually absent for supplement pairings.
Can I take Ginkgo and Saffron together?
No modeled interaction between Ginkgo and Saffron; combining is not documented to be problematic, but combined-effect trials are also absent, so treat additive benefit claims skeptically.
Have Ginkgo and Saffron been compared head-to-head?
Direct RCTs comparing the two for mood are uncommon. This page contrasts each side's own trial evidence — that is an indirect comparison, which introduces confounds from population and dose differences. See the direct-comparison block above.
What decides between Ginkgo and Saffron for me?
Read the decision guidance below — the split usually comes down to population fit, interaction risk with your other medications, and how much certainty you want behind the recommendation.
Related
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Ginkgo vs Saffron for mood. https://evidencebased.info/compare/ginkgo-vs-saffron-for-mood. Updated 2026-07-14.
BibTeX
@misc{substrate_nkgovssaffronformood,
author = {Substrate editorial},
title = {Ginkgo vs Saffron for mood},
year = {2026},
url = {https://evidencebased.info/compare/ginkgo-vs-saffron-for-mood},
note = {evidencebased.info}
}